z-logo
HomeZAIABlog
open-access-imgOpen Access
Leki stosowane u chorych na przewlekłą białaczkę limfocytową wyróżnione przez FDA statusem terapii przełomowej
Author(s) -
Rafał Zyśk,
Dariusz Wołowiec
Publication year - 2015
Publication title -
hematologia
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.136
H-Index - 5
eISSN - 2081-3287
pISSN - 2081-0768
DOI - 10.5603/hem.2015.0036
Subject(s) - medicine , theology , gynecology , philosophy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

AboutCareersPublisher PartnersContact UsGet Organisational Trial or Quote

Learn

FAQsBlogTerms of UsePrivacy Policy

Download the Zendy App

Get it on
Google Play
Download on the
App Store

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.